FLT3 and acute myeloid leukemia: Aim of this retrospective single center study was to evaluate the frequency of CNS relapse in patients with FLT3-mutated AML who underwent HCT, to determine underlying risk factors and to analyze the impact of FLT3-targeted therapies.